Advertisement

Effects on Mouse Thymocyte Biology

A Mini-Overview with Some New Evidence
  • David W. Ou
  • Mei-ling Shen
  • Ken M. Anderson
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 402)

Abstract

The alkaloid designated cocaine, derived from the leaves of the Anean coca bush (Erythroxylon coca) was first isolated and identified in 1860 by the German chemist, Albert Niemann. Cocaine is used medically in nasal surgery as a topical anesthesia but most of its interest is related to its potential as a powerful addicting narcotic. Its ready availability and the ease with which its use leads to psychological compulsion and physical dependency provides an important impetus for understanding its mechanisms of action, both on the nervous system and other organ systems.

Keywords

Cocaine Injection Peripheral Blood Mononuclear Cell Culture Cocaine Concentration Erythroxylon Coca Normal Thymocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Farrar HC, Kearns GL, Cocaine: Clinical pharmacology and toxicology. J. Pediatr., 115, 665, 1989.PubMedCrossRefGoogle Scholar
  2. 2.
    Gawin, F, Cocaine addiction: Psychology and Neurophysiology. Science, 251, 1580–1586, 1991.PubMedCrossRefGoogle Scholar
  3. 3.
    Chambers, HF, Morris DL, Tauber MG, Modin G, Cocaine use and the risk for endocarditis in intravenous drug users. Ann. Intern. Med., 106, 833–836, 1987.Google Scholar
  4. 4.
    Chaisson RE, Bacchetti P, Osmond MA, Brodie B, Sande MA, and Moss AR, Cocaine use and HIV infection in intravenous drug users in San Francisco. J. AM. Med. Assoc., 261, 561–565, 1989.CrossRefGoogle Scholar
  5. 5.
    Peterson PK, Gekker G, Chao CC, Schut R, Molitor TW, and Balfour HH, Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cultures. J. Immunol., 146, 81–84. 1991.PubMedGoogle Scholar
  6. 6.
    Peterson PK. Gekker G, Chao CC, Schut R, Verhoef J, Edelman CK, Erice A, and Balfour HI-I, Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. J. Immunol., 140, 676-680, 1992.Google Scholar
  7. 7.
    D’Elia JA., Weinrauch LA, Paine DF, Domey PE, and Kaldany A, Increased infection rate in diabetic dialysis patients exposed to cocaine. Am. J. Kidney Dis.. 18, 349–352, 1991.PubMedGoogle Scholar
  8. 8.
    Watson ES, Murphy JC, Elsohly MA. Elsohly HN, and Turner CE, Effects of the administration of coca alkaloids on the primary immune responses of mice: interaction with delta-9-tetrahydrocannabinol and ethanol, Toxicol. Appl. Pharmacol., 71, 1. 1983.Google Scholar
  9. 9.
    Matsui K, Freidman, H, and Klein TW, Cocaine augments proliferation of human peripheral blood T-lymphocytes activated with anti-CD3 antibody. Int. J. Inmmnopharmac., 14, 7, 1213–1220, 1992CrossRefGoogle Scholar
  10. 10.
    Van Dyke C, Stesin A, Jones R, Chuntharapal A, Seaman W, Cocaine increases natural killer cell activity, J. Clin. Invest., 77, 1387, 1986.PubMedCrossRefGoogle Scholar
  11. 11.
    Ou DW, Shen ML, and Luo YD, Effects of cocaine on the immune system in Balb/C mice. Clin. Immuno. Immunopathol., 52, 305–312, 1989.CrossRefGoogle Scholar
  12. 12.
    Klein TW, Matsui K, Newton CA, Young J, Widen RE, and Friedman H, Cocaine suppresses proliferation of phytohemagglutinin-activated human peripheral blood T-cells. Int. J. Immunopharmac., 15, 1, 77–86, 1993CrossRefGoogle Scholar
  13. 13.
    Lu F, and Ou DW, Cocaine or delta 9-tetrahydrocannabinol does not affect cellular cytotoxicity in vitro. Int. J. Immunopharmac. 11, 849, 1989.CrossRefGoogle Scholar
  14. 14.
    Havas HF, Dellaria M, Schiffiman G, Geller EB, Adler MW, Effect of cocaine on the immune response and host resistance in Balb/C mice. Int. Archs. Allergy Appl. Immun, 83, 377–383, 1987.CrossRefGoogle Scholar
  15. 15.
    Waltz B., and Watson RR., Immunodulation by cocaine — A neuroendocrine mediated response. Life Sci., 46, 1319–1329, 1990.CrossRefGoogle Scholar
  16. 16.
    Jeong TC, Matulka RA., Jordan SD, Yang KH, Holsapple MP, Role of metabolism in cocaine-induced immunoisuppression in splenocyte cultures from B6C3F1 female mice. Immunopharmac., 29, 37–46, 1995.CrossRefGoogle Scholar
  17. 17.
    Klein TW, Newton C., and Friedman H, Cocaine effects on cultured lymphocytes. Drugs of Abuse, Immunity, and Inmiunodeficiency, 151–158, 1991.Google Scholar
  18. 18.
    Delafuente JC, and DeVane L, Immunologic effects of cocaine and related alkaloids. Immunopharmac. Immunotoxicol., 13 (1&2), 11–23, 1991.CrossRefGoogle Scholar
  19. 19.
    Abbas AK, Lichtman AH, and Pober JS, Cellular & Molecular Immunology, 179–182, 1991.Google Scholar
  20. 20.
    Hagen KL, Shen ML, and Ou DW, The effects of cocaine on cellularity, subclass composition, and apoptosis of the mouse thymus. J. Immunol., 152, 6, 113 (3328), 1994Google Scholar
  21. 21.
    Lopez MC, Colombo LL, Huang DS, Wang YJ, and Watson RR, Modification of thymic cell subsets induced by long-term cocaine administration during a murine retroviral infection producing AIDS. Clin. Immunol. Immunopathol., 65, 1, 45–52, 1992.PubMedCrossRefGoogle Scholar
  22. 22.
    Kump DF, Matulka RA, Edinboro LE, Poklis A, and Holsapple MP, Disposition of cocaine and norcocaine in blood and tissues of B6C3F1 mice. J. Anal. Toxicol., 18, 342–345, 1994.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • David W. Ou
    • 1
  • Mei-ling Shen
    • 1
  • Ken M. Anderson
    • 2
  1. 1.Department of PathologyUniversity of Illinois at ChicagoUSA
  2. 2.Departments of Medicine and BiochemistryRush Medical CollegeChicagoUSA

Personalised recommendations